tiprankstipranks
Trending News
More News >
Healthcare Triangle (HCTI)
NASDAQ:HCTI
US Market

Healthcare Triangle (HCTI) AI Stock Analysis

Compare
108 Followers

Top Page

HC

Healthcare Triangle

(NASDAQ:HCTI)

27Underperform
Healthcare Triangle is currently in a challenging financial position with negative revenue growth, persistent losses, and negative equity. The technical analysis further highlights a bearish trend, with the stock trading below key moving averages. Valuation metrics are poor, with a negative P/E ratio and no dividend yield. While the new CFO appointment is a positive corporate event, it is not sufficient to offset the overall negative outlook.

Healthcare Triangle (HCTI) vs. S&P 500 (SPY)

Healthcare Triangle Business Overview & Revenue Model

Company DescriptionHealthcare Triangle (HCTI) is a leading provider of cloud and data transformation services tailored to the healthcare and life sciences sectors. The company leverages its expertise in cloud technology, data analytics, and security to offer solutions that enhance operational efficiency, compliance, and patient outcomes. HCTI's core services include cloud migration, managed services, data analytics, and AI-powered solutions designed to meet the unique needs of healthcare organizations.
How the Company Makes MoneyHealthcare Triangle generates revenue primarily through its comprehensive suite of cloud and data services offered to healthcare providers, payers, and life sciences companies. The company makes money by delivering subscription-based cloud services, consulting fees for data analytics and transformation projects, and managed services contracts. Additionally, HCTI partners with major cloud providers like AWS, Google Cloud, and Microsoft Azure, which enhances its service offerings and expands its market reach. These strategic partnerships, along with a focus on innovation and compliance with healthcare regulations, are significant factors contributing to its earnings.

Healthcare Triangle Financial Statement Overview

Summary
Healthcare Triangle is facing significant financial difficulties. The company has been unable to generate positive revenues or profits, and its balance sheet reflects negative equity, indicating financial instability. The cash flow situation is also concerning, with ongoing negative cash flows. Overall, the company is in a precarious financial position.
Income Statement
20
Very Negative
The company has experienced declining revenues from $45.89M in 2022 to $11.70M in 2024, leading to negative revenue growth rates. Gross profit margins have been low, and both EBIT and EBITDA margins are negative, indicating ongoing operational challenges. Net profit margins are also negative, reflecting persistent losses.
Balance Sheet
15
Very Negative
The balance sheet shows a negative stockholders' equity of -$5.11M in 2024, indicating financial distress. The equity ratio is negative, and the company has high liabilities relative to its assets. The debt-to-equity ratio cannot be calculated due to negative equity, highlighting potential solvency issues.
Cash Flow
25
Negative
The company has consistently negative operating and free cash flows, indicating cash flow challenges. Free cash flow growth is negative, reflecting an inability to generate cash. The operating cash flow to net income ratio is unfavorable due to negative figures.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
11.70M33.20M45.89M35.27M31.34M
Gross Profit
2.89M6.78M11.29M10.52M8.59M
EBIT
-4.75M-11.35M-10.42M-5.36M1.18M
EBITDA
-3.85M-4.10M-5.96M-3.94M1.98M
Net Income Common Stockholders
-5.97M-12.34M-9.61M-5.95M2.35M
Balance SheetCash, Cash Equivalents and Short-Term Investments
20.00K1.23M1.34M1.77M1.40M
Total Assets
1.96M10.05M20.76M24.61M11.11M
Total Debt
2.65M4.32M2.41M3.45M754.40K
Net Debt
2.63M3.08M1.07M1.68M-648.30K
Total Liabilities
7.08M9.51M8.38M8.48M6.78M
Stockholders Equity
-5.11M538.00K12.39M16.13M4.33M
Cash FlowFree Cash Flow
-1.08M-1.63M-5.92M-10.42M-1.21M
Operating Cash Flow
-1.08M-1.61M-2.60M-7.29M-734.67K
Investing Cash Flow
0.00-13.00K-3.32M-7.63M-477.46K
Financing Cash Flow
-133.00K1.52M5.49M15.29M1.64M

Healthcare Triangle Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.04
Price Trends
50DMA
0.26
Negative
100DMA
0.50
Negative
200DMA
0.61
Negative
Market Momentum
MACD
-0.03
Positive
RSI
30.63
Neutral
STOCH
12.22
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HCTI, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.19, below the 50-day MA of 0.26, and below the 200-day MA of 0.61, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 30.63 is Neutral, neither overbought nor oversold. The STOCH value of 12.22 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HCTI.

Healthcare Triangle Risk Analysis

Healthcare Triangle disclosed 44 risk factors in its most recent earnings report. Healthcare Triangle reported the most risks in the “Legal & Regulatory” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Healthcare Triangle Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
52
Neutral
$5.15B3.02-44.64%2.83%16.44%-0.47%
45
Neutral
$4.44M-192.85%-100.00%5.43%
41
Neutral
$3.64M-181.43%109.29%-206.99%
31
Underperform
$2.85M367.65%-100.00%69.07%
28
Underperform
$2.69M-49.77%71.41%
27
Underperform
$357.17K-292.41%-64.77%43.53%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HCTI
Healthcare Triangle
0.04
-0.74
-94.87%
GLMD
Galmed Pharmaceuticals
1.28
-3.49
-73.17%
MTNB
Matinas BioPharma
0.76
-7.62
-90.93%
QLGN
Qualigen Therapeutics
3.79
-10.96
-74.31%
SXTP
60 Degrees Pharmaceuticals, Inc.
2.32
-14.42
-86.14%

Healthcare Triangle Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Healthcare Triangle Announces New CFO Appointment
Positive
Apr 11, 2025

On April 10, 2025, Healthcare Triangle announced significant leadership changes with the resignation of CFO Thyagarajan Ramachandran and the appointment of David Ayanoglou as the new CFO. Ayanoglou brings over 23 years of corporate finance experience, notably in software M&A and financial reporting, which is expected to drive the company’s strategic growth. Additionally, Sujatha Ramesh was appointed as a Director on the Board, reinforcing the company’s commitment to operational excellence and digital innovation. Ramesh’s extensive experience in technology and financial services is anticipated to enhance the company’s leadership team as it continues its global expansion and transformation initiatives.

Spark’s Take on HCTI Stock

According to Spark, TipRanks’ AI Analyst, HCTI is a Underperform.

Healthcare Triangle is facing substantial financial challenges with negative revenue growth, persistent losses, and negative equity. The technical analysis indicates a bearish trend, with the stock trading below key moving averages. The lack of positive earnings and dividend yield further exacerbates the company’s weak position. These factors collectively contribute to a low overall stock score.

To see Spark’s full report on HCTI stock, click here.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.